Logan Capital Management Inc Mirati Therapeutics, Inc. Transaction History

Logan Capital Management Inc

  • $2.34 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 14, 2019
SELL
$32.0 - $47.43 $204,800 - $303,552
-6,400 Closed
0 $0
Q3 2018

Nov 13, 2018
BUY
$47.1 - $62.7 $18,840 - $25,080
400 Added 6.67%
6,400 $301,000
Q2 2018

Aug 14, 2018
BUY
$26.05 - $52.4 $156,300 - $314,400
6,000 New
6,000 $296,000

Others Institutions Holding MRTX

# of Institutions
16
Shares Held
3.57M
Call Options Held
0
Put Options Held
36.6K
View Full List

About Mirati Therapeutics, Inc.

MRTX Quotes by TradingView
  • Ticker MRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,609,800
  • Description
  • Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...
More about MRTX
Track This Portfolio

Track Logan Capital Management Inc Portfolio

Follow Logan Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Logan Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Logan Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email